Critical care comprises nearly 20% of Edwards’ revenue. Its continued growth is connected to the prominence of the company’s heart valve business.
Katie Szyman spent 23 years at Medtronic, a giant in the Medtech industry, but a patient-focused outlook became a driving force behind a change for her.
Wanting to work for a California-based company “focused on the patient and innovation” led Szyman to where she is now — a corporate VP and the GM of critical care at Edwards Lifesciences (NYSE:EW).
Get the full story at our sister site, Medical Design & Outsourcing.
